Adam Brenner, BS

Peter J. Kaboli, MD
Center for Research in the Implementation of Innovative Strategies in Practice, Iowa City VA Medical Center, and the Division of General Internal Medicine, University of Iowa Carver College of Medicine, Iowa City, Iowa

Adam Brenner, BS
Division of General Internal Medicine, Mount Sinai School of Medicine, New York, NY

Andrew S. Dunn, MD
Division of General Internal Medicine, Mount Sinai School of Medicine, New York, NY

Correspondence: Peter J. Kaboli, MD, Division of General Internal Medicine, University of Iowa Hospitals and Clinics, SE615GH, 200 Hawkins Drive, Iowa City, IA 52242; peter-kaboli@uiowa.edu

Dr. Kaboli is supported by a Research Career Development Award from the Health Services Research and Development Service, Department of Veterans Affairs (RCD 03-033-1).

Dr. Kaboli has received grant/research support from Sanofi-Aventis, is a consultant for Sanofi-Aventis and AstraZeneca, and is on the speakers' bureau of Sanofi-Aventis.

Mr. Brenner has indicated that he has nothing to disclose.

Dr. Dunn has received grant/research support from Sanofi-Aventis.

Peter J. Kaboli, MD
Center for Research in the Implementation of Innovative Strategies in Practice, Iowa City VA Medical Center, and the Division of General Internal Medicine, University of Iowa Carver College of Medicine, Iowa City, Iowa

Adam Brenner, BS
Division of General Internal Medicine, Mount Sinai School of Medicine, New York, NY

Andrew S. Dunn, MD
Division of General Internal Medicine, Mount Sinai School of Medicine, New York, NY

Correspondence: Peter J. Kaboli, MD, Division of General Internal Medicine, University of Iowa Hospitals and Clinics, SE615GH, 200 Hawkins Drive, Iowa City, IA 52242; peter-kaboli@uiowa.edu

Dr. Kaboli is supported by a Research Career Development Award from the Health Services Research and Development Service, Department of Veterans Affairs (RCD 03-033-1).

Dr. Kaboli has received grant/research support from Sanofi-Aventis, is a consultant for Sanofi-Aventis and AstraZeneca, and is on the speakers' bureau of Sanofi-Aventis.

Mr. Brenner has indicated that he has nothing to disclose.

Dr. Dunn has received grant/research support from Sanofi-Aventis.

Peter J. Kaboli, MD
Center for Research in the Implementation of Innovative Strategies in Practice, Iowa City VA Medical Center, and the Division of General Internal Medicine, University of Iowa Carver College of Medicine, Iowa City, Iowa

Adam Brenner, BS
Division of General Internal Medicine, Mount Sinai School of Medicine, New York, NY

Andrew S. Dunn, MD
Division of General Internal Medicine, Mount Sinai School of Medicine, New York, NY

Correspondence: Peter J. Kaboli, MD, Division of General Internal Medicine, University of Iowa Hospitals and Clinics, SE615GH, 200 Hawkins Drive, Iowa City, IA 52242; peter-kaboli@uiowa.edu

Dr. Kaboli is supported by a Research Career Development Award from the Health Services Research and Development Service, Department of Veterans Affairs (RCD 03-033-1).

Dr. Kaboli has received grant/research support from Sanofi-Aventis, is a consultant for Sanofi-Aventis and AstraZeneca, and is on the speakers' bureau of Sanofi-Aventis.

Mr. Brenner has indicated that he has nothing to disclose.

Dr. Dunn has received grant/research support from Sanofi-Aventis.